Latest ebit for SLHG: $-20M, below the Consumer Staples sector average of $7.9T.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022
Skylight Health Group posts a EBIT of $-20M as of September 2022. That compares with $-16M in the prior-year period — down 28.5% year over year. That is below the Consumer Staples sector average of $7.9T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Skylight Health Group's EBIT was $-16M. The latest reading is $-20M — a 28.5% year-over-year decrease (period ending September 2022). Use the history and growth charts on this page for a longer lookback.
For Consumer Staples stocks, a EBIT near $7.9T is typical. Skylight Health Group's $-20M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
EBIT is one piece of Skylight Health Group's financial statement story. At $-20M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for SLHG's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $7.9T), and (3) consistency with growth and profitability. This page covers the first two; Skylight Health Group's other metric pages and overview cover the third.